About Triphase Pharmaceuticals Private Limited
Data last updated:
Triphase Pharmaceuticals Private Limited is a private limited company based in Mysore, Karnataka, India, a subsidiary of Tenshi Kaizen Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2006PTC039605. Its GSTIN is 29AACCT5097P1ZF (Karnataka).
The company has an authorised share capital of ₹16.5 Lakh and a paid-up capital of ₹12.5 Lakh. It is led by directors Perumal Manoharan and Aditya Desiraju.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No 694 Double Road Saraswathipuram, Mysore, Karnataka, India – 570009.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.03 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.36 Cr and EBITDA of -₹2.3 Cr. Revenue has declined at a compounded annual rate (CAGR) of 107% over three years and 19% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Triphase Pharmaceuticals. Court records list 10 cases involving the company, including 4 filed by the company and 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website triphasepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo 694 Double Road Saraswathipuram, Mysore, Karnataka, India – 570009
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Triphase Pharmaceuticals Private Limited
The main business activity of Triphase Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Triphase Pharmaceuticals Private Limited FY 2023 filings available
Triphase Pharmaceuticals Private Limited reported revenue of ₹6.03 Lakh (up 233% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Triphase Pharmaceuticals Private Limited
Revenue rose 233% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 19%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Triphase Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹6.03 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.3 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.36 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Triphase Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Triphase Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Perumal Manoharan Also directs: Mayuresh Business Consultancy Private Limited | Director | 02 Mar 2023 | 3 Years 7 Months | Current |
| Aditya Desiraju Also directs: Synbiopro Nutraceutix (OPC) Private Limited | Director | 02 Mar 2023 | 3 Years 7 Months | Current |
Ownership and Shareholding of Triphase Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited has 10 court cases on record: 4 filed by Triphase Pharmaceuticals, 4 filed against it, 2 where it is another party. All cases are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 3 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Interim or miscellaneous application | Filed by the company against Omega Scientific Instruments Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Execution petition | Filed against the company by Omega Scientific Instruments Private Limited | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed against the company by Instapill Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Court case (AA) | Filed against the company by Instapill Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.A.A.) | Filed against the company by Instapill Private Limited | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited has 8 MSME Form 1 returns on record between 2015 and 2021, listing 17 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pci Pest Control Private Limited | •••• | •••• | •••• |
| Katalyst Bio Engineering | •••• | •••• | •••• |
| Spire Automation and Innovation | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals operates one associated brand: Triphase Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. | triphasepharma.com |
Employees and EPFO Compliance at Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited has a workforce of 12 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals Private Limited has 12 board changes on record since 2016: 2 appointments and 10 cessations. The latest: Perumal Manoharan ceased to be Additional Director on 29 Sep 2023.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Triphase Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Triphase Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCT5097P1ZF | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Triphase Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals is an active private limited company based in Mysore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2006 (20+ years old) and is registered under CIN U73100KA2006PTC039605.
Triphase Pharmaceuticals reported revenue of ₹6.03 Lakh for FY 2022 (up 233% YoY).
Triphase Pharmaceuticals has 2 current directors:
- Perumal Manoharan - Director
- Aditya Desiraju - Director
Triphase Pharmaceuticals reported a net loss of ₹3.36 Cr and EBITDA of -₹2.3 Cr for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Triphase Pharmaceuticals is 107% over three years and -19% over five years. In the latest year (FY 2022) revenue rose 233%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Triphase Pharmaceuticals is 29AACCT5097P1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Triphase Pharmaceuticals is U73100KA2006PTC039605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triphase Pharmaceuticals has 10 court cases on record: 4 filed by the company and 4 filed against it. Most are in the district courts.
Triphase Pharmaceuticals was incorporated on 01 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
Perumal Manoharan ceased to be Additional Director on 29 Sep 2023. Aditya Arun Kumar ceased to be Director on 02 Mar 2023. Aditya Desiraju was appointed as Director on 02 Mar 2023. Triphase Pharmaceuticals has 12 board changes on record in total.
Triphase Pharmaceuticals has 8 MSME Form 1 returns on record between 2015 and 2021, listing 17 overdue payments to 8 micro and small suppliers. The latest return was filed on 18 Oct 2021.